ERCC excision repair 6 like 2 (ERCC6L2) gene encodes for different helicase-like protein members of the Snf2 family involved in transcription-coupled nucleotide excision repair and in cell proliferation. Germline homozygous mutations in children and adults predispose to a peculiar bone marrow failure phenotype characterized by mild hematological alterations with a high risk of developing acute myeloid leukemia. The outcome for patients with leukemia progression is dismal while patients undergoing hematopoietic stem cell transplantation in the early stage have better outcomes. The ERCC6L2-related hematological disease presents a high penetrance, posing important questions regarding the treatment strategies and possible preemptive approaches. This review describes the biological function of ERCC6L2 and the clinical manifestations of the associated disease, trying to focus on the unsolved clinical questions.
Baccelli, F., Leardini, D., Cerasi, S., Messelodi, D., Bertuccio, S.N., Masetti, R. (2023). ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution. ANNALS OF HEMATOLOGY, 102(4), 699-705 [10.1007/s00277-023-05128-2].
ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution
Baccelli, Francesco;Leardini, Davide
;Cerasi, Sara;Messelodi, Daria;Bertuccio, Salvatore Nicola;Masetti, Riccardo
2023
Abstract
ERCC excision repair 6 like 2 (ERCC6L2) gene encodes for different helicase-like protein members of the Snf2 family involved in transcription-coupled nucleotide excision repair and in cell proliferation. Germline homozygous mutations in children and adults predispose to a peculiar bone marrow failure phenotype characterized by mild hematological alterations with a high risk of developing acute myeloid leukemia. The outcome for patients with leukemia progression is dismal while patients undergoing hematopoietic stem cell transplantation in the early stage have better outcomes. The ERCC6L2-related hematological disease presents a high penetrance, posing important questions regarding the treatment strategies and possible preemptive approaches. This review describes the biological function of ERCC6L2 and the clinical manifestations of the associated disease, trying to focus on the unsolved clinical questions.File | Dimensione | Formato | |
---|---|---|---|
s00277-023-05128-2.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
936.99 kB
Formato
Adobe PDF
|
936.99 kB | Adobe PDF | Visualizza/Apri |
5128.zip
accesso aperto
Tipo:
File Supplementare
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
59.43 kB
Formato
Zip File
|
59.43 kB | Zip File | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.